|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 107.47 USD | +0.91% |
|
+3.19% | +35.42% |
| 07-17 | CVS Health Opens Pharmacy-Focused Location in Houston | MT |
| 07-17 | Cvs Health Unveils First Pharmacy-Focused Cvs Pharmacy Location in Houston | CI |
| Market Cap | 137B 120B 111B 102B 192B 13,201B 197B 1,321B 520B 6,454B 515B 504B 22,284B | P/E 2026 * |
17.1x | P/E 2027 * | 14.9x |
|---|---|---|---|---|---|
| Enterprise Value | 193B 169B 156B 144B 270B 18,574B 277B 1,859B 731B 9,081B 725B 709B 31,354B | EV / Sales 2026 * |
0.47x | EV / Sales 2027 * | 0.44x |
| Free-Float |
71.2% | Yield 2026 * |
2.47% | Yield 2027 * | 2.55% |
Last Transcript: CVS Health Corporation
| 1 day | +0.91% | ||
| 1 week | +3.19% | ||
| Current month | +3.89% | ||
| 1 month | +9.31% | ||
| 3 months | +39.03% | ||
| 6 months | +36.73% | ||
| Current year | +35.42% |
| 1 week | 103.56 |  | 108.97 |
| 1 month | 99 | | 108.97 |
| Current year | 69.51 | | 108.97 |
| 1 year | 58.5 | | 108.97 |
| 3 years | 43.56 | | 108.97 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
Ali Keshavarz
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/26/26 | Tax | Controller/Auditor | -454 | 0.0000% | ||
| 5/31/26 | Tax | Chief Financial Officer | -2,478 | 0.0002% | ||
| 5/31/26 | Tax | Chief Technology Officer | -7,618 | 0.0006% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.91% | +3.19% | +73.45% | +48.62% | 137B | |
| -3.77% | -8.71% | +2.79% | +28.11% | 82.34B | |
| -0.24% | -1.97% | +2.05% | +56.82% | 26.9B | |
| +0.61% | +1.56% | +26.22% | +50.10% | 23.32B | |
| -0.51% | +0.23% | -15.62% | -28.43% | 20.05B | |
| -2.15% | -4.57% | +11.34% | +142.27% | 16.79B | |
| -0.25% | -0.67% | +8.79% | +8.52% | 15.38B | |
| +1.26% | +1.79% | +67.87% | +123.22% | 15.21B | |
| +0.45% | +0.74% | -8.05% | -13.14% | 12.84B | |
| -0.81% | -1.66% | -10.40% | +80.55% | 11.01B | |
| Average | -0.45% | -0.96% | +15.84% | +49.66% | 36.1B | |
| Weighted average by Cap. | -0.59% | -0.97% | +32.68% | +44.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 409B 358B 331B 305B 574B 39,414B 587B 3,945B 1,552B 19,270B 1,537B 1,504B 66,533B | 427B 373B 345B 317B 598B 41,078B 612B 4,112B 1,617B 20,084B 1,602B 1,567B 69,343B |
| Net income | 8.04B 7.04B 6.5B 5.98B 11.28B 774B 11.54B 77.52B 30.49B 379B 30.21B 29.55B 1,307B | 9.35B 8.18B 7.55B 6.95B 13.1B 900B 13.4B 90.06B 35.42B 440B 35.1B 34.32B 1,519B |
| Net Debt | 55.81B 48.83B 45.11B 41.51B 78.23B 5,373B 80.04B 538B 212B 2,627B 210B 205B 9,070B | 52.23B 45.7B 42.21B 38.85B 73.21B 5,028B 74.91B 503B 198B 2,458B 196B 192B 8,488B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | US$107.47 | +0.91% | 6,608,659 |
| 26-07-16 | US$106.50 | +0.56% | 12,025,143 |
| 26-07-15 | US$105.91 | -0.25% | 6,939,634 |
| 26-07-14 | US$106.18 | +0.26% | 11,396,143 |
| 26-07-13 | US$105.90 | +1.68% | 7,264,352 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
